Invasive procedure a breath of fresh air for asthma patients

COIMBATORE: Ramakrishnan, a senior citizen from Pappampati Pirivu and an asthmatic, was afraid to ride bicycles or even step out before 8.30am during the winter. Fearing an asthma attack, he avoided bus rides. Even his reliever inhaler could not control the bouts of wheezing, often forcing him to spend a day in hospital.

But after undergoing bronchial thermoplasty in June last year, Ramakrishnan’s life has changed dramatically. “For the last one year, I have been cycling even up to 10km and going out early in the mornings even on cold and misty days,” he told TOI.

Bronchial thermoplasty involves a doctor guiding a catheter into the windpipe to see air passages. The instrument raises the temperature in the airways using therapeutic radio frequency energy for 10 seconds to shrink the muscle so that they don’t swell during asthma attack and restrict breathing.

Three patients, who underwent the invasive procedure a year ago, met at Royal Care Hospital to discuss about the asthma-free life. “They still need inhalers and take precautions after the treatment. But it definitely removed hospitalization and the need for more steroids,” said pulmonologist Dr V R Pattabhiraman.

Ramakrishnan is among the 10% of asthma patients in the district, who suffer from severe asthma. “In Coimbatore, almost 10% of asthma patients suffer from sever asthma, where inhalers do not help. They require hospitalization almost twice or thrice a year and higher doses of oral steroids. It is for these patients that thermoplasty helps,” the doctor said.

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra